Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,583,000 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | -544,000 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | -263,000 | 282,000 | -72,000 | -79,000 |
| Other Working Capital | 423,000 | -309,000 | 62,000 | 332,000 | -543,000 |
| Other Operating Activity | 3,908,000 | 1,390,000 | 947,000 | 1,258,000 | 1,189,000 |
| Operating Cash Flow | $5,370,000 | $818,000 | $1,291,000 | $1,518,000 | $567,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -444,000 | -406,000 | -375,000 | -298,000 |
| Net Acquisitions | -5,842,000 | -50,000 | 420,000 | -2,917,000 | -2,000 |
| Purchase Of Investment | -148,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,303,000 | N/A | N/A | 430,000 | N/A |
| Purchase Sale Intangibles | N/A | -57,000 | -96,000 | 70,000 | -139,000 |
| Other Investing Activity | -915,000 | -168,000 | -489,000 | -171,000 | 301,000 |
| Investing Cash Flow | $-5,602,000 | $-755,000 | $-583,000 | $-3,116,000 | $-143,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,061,000 | -24,000 | -127,000 | 2,756,000 | 46,000 |
| Debt Issued | N/A | 0 | 0 | 0 | 809,000 |
| Debt Repayment | -5,000 | -24,000 | -83,000 | -51,000 | -110,000 |
| Common Stock Repurchased | -757,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -2,144,000 | -14,000 | 0 | N/A | -284,000 |
| Other Financing Activity | 5,729,000 | 0 | 0 | -1,000 | -718,000 |
| Financing Cash Flow | $1,762,000 | $-62,000 | $-210,000 | $2,704,000 | $-257,000 |
| Exchange Rate Effect | -37,000 | 3,000 | -10,000 | -21,000 | -6,000 |
| Beginning Cash Position | 5,398,000 | 2,740,000 | 2,251,000 | 1,166,000 | 1,005,000 |
| End Cash Position | 6,891,000 | 2,743,000 | 2,740,000 | 2,251,000 | 1,166,000 |
| Net Cash Flow | $1,530,000 | $1,000 | $498,000 | $1,106,000 | $167,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,370,000 | 818,000 | 1,291,000 | 1,518,000 | 567,000 |
| Capital Expenditure | -893,000 | -546,000 | -528,000 | -461,000 | -444,000 |
| Free Cash Flow | 4,477,000 | 272,000 | 763,000 | 1,057,000 | 123,000 |